Healthy Volunteers
Showing NaN - NaN of 21
Healthy Volunteers, Dyslipidaemia Trial in Cypress (NNC0491-6075, Placebo)
Recruiting
- Healthy Volunteers
- Dyslipidaemia
- NNC0491-6075
- Placebo
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Aug 8, 2023
Healthy Volunteers, Type 2 Diabetes Trial in Overland Park (Semaglutide D Dose 1, Semaglutide D Dose 2, Semaglutide D Dose 3)
Active, not recruiting
- Healthy Volunteers
- Type 2 Diabetes
- Semaglutide D Dose 1
- +5 more
-
Cypress, California
- +2 more
Dec 27, 2022
Healthy Volunteers Trial in Cypress (Risankizumab, Placebo)
Completed
- Healthy Volunteers
- Risankizumab
- Placebo
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc /ID# 164197
Mar 23, 2022
Healthy Volunteers Trial in Cypress (BMS-986166, Placebo)
Completed
- Healthy Volunteers
- BMS-986166
- Placebo
-
Cypress, CaliforniaWest Coast Clinical Trials Global
Feb 24, 2022
Healthy Volunteers Trial in Cypress (Lanadelumab)
Completed
- Healthy Volunteers
-
Cypress, CaliforniaWCCT Global, Inc.
May 13, 2021
Healthy Volunteers Trial in Cypress (tanezumab)
Completed
- Healthy Volunteers
- tanezumab
-
Cypress, CaliforniaPfizer Investigational Site
Oct 2, 2020
Healthy Volunteers Trial in Cypress (rhNGF 20µg/mL, Placebo)
Completed
- Healthy Volunteers
- rhNGF 20μg/mL
- Placebo
-
Cypress, CaliforniaWCCT Global
Jun 1, 2020
Healthy Volunteers Trial in Cypress (USB005 (aclerastide) Ophthalmic Solution, USB005 Ophthalmic Solution Placebo)
Completed
- Healthy Volunteers
- USB005 (aclerastide) Ophthalmic Solution
- USB005 Ophthalmic Solution Placebo
-
Cypress, CaliforniaWCCT Global, Inc.
Apr 2, 2019
Healthy Volunteers Trial in Cypress (LY3050258, Placebo)
Completed
- Healthy Volunteers
- LY3050258
- Placebo
-
Cypress, CaliforniaFor additional information regarding investigative sites for thi
Jul 26, 2018
Healthy Volunteers Trial in Cypress (PEG-rhG-CSF, Neulasta (PEG-rhG-CSF))
Completed
- Healthy Volunteers
- PEG-rhG-CSF
- Neulasta (PEG-rhG-CSF)
-
Cypress, CaliforniaWCCT Global Inc.
Jul 2, 2018
Allergic Asthma, Atopic Dermatitis, Allergic Rhinitis Trial in United States (Placebo, Omalizumab, MEDI4212 5 mg Subcutaneous)
Completed
- Allergic Asthma
- +3 more
- Placebo
- +7 more
-
Cypress, California
- +6 more
Dec 18, 2014
Healthy Volunteers, Pharmacologic Action Trial in Cypress (Group 1 AZD3293, Group 2 AZD3293, Group 3 AZD3293)
Completed
- Healthy Volunteers
- Pharmacologic Action
- Group 1 AZD3293
- +5 more
-
Cypress, CaliforniaResearch Site
Apr 25, 2014
Healthy Volunteers, Pharmacologic Action Trial in Cypress (AZD3293 oral solution, AZD3293 tablet formulation A, AZD3293 tablet
Completed
- Healthy Volunteers
- Pharmacologic Action
- AZD3293 oral solution
- +2 more
-
Cypress, CaliforniaResearch Site
Apr 23, 2014
Healthy Volunteers Trial in Cypress (400 mg golimumab or , 200 mg golimumab or )
Completed
- Healthy Volunteers
- 400 mg golimumab or placebo
- 200 mg golimumab or placebo
-
Cypress, California(unnamed)
Sep 3, 2013